BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mikó E, Kovács T, Sebő É, Tóth J, Csonka T, Ujlaki G, Sipos A, Szabó J, Méhes G, Bai P. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells 2019;8:E293. [PMID: 30934972 DOI: 10.3390/cells8040293] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhang X, Yu L, Shi J, Li S, Yang S, Gao W, Yang S, Cheng M, Wang H, Guo Z, Geng C. Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis. Sci Rep 2021;11:14024. [PMID: 34234229 DOI: 10.1038/s41598-021-93428-w] [Reference Citation Analysis]
3 Režen T, Rozman D, Kovács T, Kovács P, Sipos A, Bai P, Mikó E. The role of bile acids in carcinogenesis. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04278-2] [Reference Citation Analysis]
4 Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther 2019;4:41. [PMID: 31637019 DOI: 10.1038/s41392-019-0074-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
5 Lasagna A, Zuccaro V, Ferraris E, Corbella M, Bruno R, Pedrazzoli P. COVID-19 and breast cancer: may the microbiome be the issue? Future Oncol 2021;17:123-6. [PMID: 33244989 DOI: 10.2217/fon-2020-0764] [Reference Citation Analysis]
6 Tzeng A, Sangwan N, Jia M, Liu CC, Keslar KS, Downs-Kelly E, Fairchild RL, Al-Hilli Z, Grobmyer SR, Eng C. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med 2021;13:60. [PMID: 33863341 DOI: 10.1186/s13073-021-00874-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Tango CN, Seo SS, Kwon M, Lee DO, Chang HK, Kim MK. Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Development. Sci Rep 2020;10:9720. [PMID: 32546712 DOI: 10.1038/s41598-020-66607-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes 2021;13:1-20. [PMID: 33535896 DOI: 10.1080/19490976.2020.1848158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Kovács T, Mikó E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev 2021. [PMID: 34967927 DOI: 10.1007/s10555-021-10013-3] [Reference Citation Analysis]
10 Regal P, Fente C, Cepeda A, Silva E. Food and omics: unraveling the role of food in breast cancer development. Current Opinion in Food Science 2021;39:197-207. [DOI: 10.1016/j.cofs.2021.03.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Al-Ansari MM, AlMalki RH, Dahabiyeh LA, Abdel Rahman AM. Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment. Metabolites 2021;11:758. [PMID: 34822416 DOI: 10.3390/metabo11110758] [Reference Citation Analysis]
12 Szántó M, Dózsa A, Antal D, Szabó K, Kemény L, Bai P. Targeting the gut-skin axis-Probiotics as new tools for skin disorder management? Exp Dermatol 2019;28:1210-8. [PMID: 31386766 DOI: 10.1111/exd.14016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
13 Parida S, Sharma D. The Microbiome-Estrogen Connection and Breast Cancer Risk. Cells 2019;8:E1642. [PMID: 31847455 DOI: 10.3390/cells8121642] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
14 Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers (Basel) 2020;12:E2465. [PMID: 32878124 DOI: 10.3390/cancers12092465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
15 Le Noci V, Bernardo G, Bianchi F, Tagliabue E, Sommariva M, Sfondrini L. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression. Front Cell Dev Biol 2021;9:732192. [PMID: 34604233 DOI: 10.3389/fcell.2021.732192] [Reference Citation Analysis]
16 Bobin-Dubigeon C, Luu HT, Leuillet S, Lavergne SN, Carton T, Le Vacon F, Michel C, Nazih H, Bard JM. Faecal Microbiota Composition Varies between Patients with Breast Cancer and Healthy Women: A Comparative Case-Control Study. Nutrients 2021;13:2705. [PMID: 34444865 DOI: 10.3390/nu13082705] [Reference Citation Analysis]
17 Park J, Shin Y, Kim TH, Kim DH, Lee A. Plasma metabolites as possible biomarkers for diagnosis of breast cancer. PLoS One 2019;14:e0225129. [PMID: 31794572 DOI: 10.1371/journal.pone.0225129] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
18 Giallourou N, Urbaniak C, Puebla-Barragan S, Vorkas PA, Swann JR, Reid G. Characterizing the breast cancer lipidome and its interaction with the tissue microbiota. Commun Biol 2021;4:1229. [PMID: 34707244 DOI: 10.1038/s42003-021-02710-0] [Reference Citation Analysis]
19 Di Lorenzo A, Bolli E, Tarone L, Cavallo F, Conti L. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. Int J Mol Sci 2020;21:E9418. [PMID: 33321934 DOI: 10.3390/ijms21249418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Smolková K, Mikó E, Kovács T, Leguina-Ruzzi A, Sipos A, Bai P. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. Antioxid Redox Signal 2020;33:966-97. [PMID: 31989830 DOI: 10.1089/ars.2020.8024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
21 Rossi T, Vergara D, Fanini F, Maffia M, Bravaccini S, Pirini F. Microbiota-Derived Metabolites in Tumor Progression and Metastasis. Int J Mol Sci 2020;21:E5786. [PMID: 32806665 DOI: 10.3390/ijms21165786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Meng Z, Ye Z, Zhu P, Zhu J, Fang S, Qiu T, Li Y, Meng L. New Developments and Opportunities of Microbiota in Treating Breast Cancers. Front Microbiol 2022;13:818793. [DOI: 10.3389/fmicb.2022.818793] [Reference Citation Analysis]
23 Alpuim Costa D, Nobre JG, Batista MV, Ribeiro C, Calle C, Cortes A, Marhold M, Negreiros I, Borralho P, Brito M, Cortes J, Braga SA, Costa L. Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine. Front Microbiol 2021;12:584332. [PMID: 33716996 DOI: 10.3389/fmicb.2021.584332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hou MF, Ou-Yang F, Li CL, Chen FM, Chuang CH, Kan JY, Wu CC, Shih SL, Shiau JP, Kao LC, Kao CN, Lee YC, Moi SH, Yeh YT, Cheng CJ, Chiang CP. Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer. Exp Mol Med 2021;53:1636-46. [PMID: 34707191 DOI: 10.1038/s12276-021-00686-9] [Reference Citation Analysis]
25 Ballini A, Scacco S, Boccellino M, Santacroce L, Arrigoni R. Microbiota and Obesity: Where Are We Now? Biology (Basel) 2020;9:E415. [PMID: 33255588 DOI: 10.3390/biology9120415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
26 Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int J Mol Sci 2019;20:E4145. [PMID: 31450659 DOI: 10.3390/ijms20174145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
27 Cai M, Kandalai S, Tang X, Zheng Q, Xu ZZ. Contributions of Human-Associated Archaeal Metabolites to Tumor Microenvironment and Carcinogenesis. Microbiol Spectr. [DOI: 10.1128/spectrum.02367-21] [Reference Citation Analysis]
28 Ruo SW, Alkayyali T, Win M, Tara A, Joseph C, Kannan A, Srivastava K, Ochuba O, Sandhu JK, Went TR, Sultan W, Kantamaneni K, Poudel S. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment. Cureus 2021;13:e17472. [PMID: 34513524 DOI: 10.7759/cureus.17472] [Reference Citation Analysis]
29 Prochownik EV, Wang H. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells. Cells 2021;10:762. [PMID: 33808495 DOI: 10.3390/cells10040762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Arnone AA, Cline JM, Soto-Pantoja DR, Cook KL. Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling. Breast Cancer Res Treat 2021;190:53-67. [PMID: 34448090 DOI: 10.1007/s10549-021-06354-w] [Reference Citation Analysis]
31 Ravnik Z, Muthiah I, Dhanaraj P. Computational studies on bacterial secondary metabolites against breast cancer. J Biomol Struct Dyn 2021;39:7056-64. [PMID: 32779523 DOI: 10.1080/07391102.2020.1805361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Laborda-Illanes A, Sánchez-Alcoholado L, Boutriq S, Plaza-Andrades I, Peralta-Linero J, Alba E, González-González A, Queipo-Ortuño MI. A New Paradigm in the Relationship between Melatonin and Breast Cancer: Gut Microbiota Identified as a Potential Regulatory Agent. Cancers (Basel) 2021;13:3141. [PMID: 34201776 DOI: 10.3390/cancers13133141] [Reference Citation Analysis]
33 Sári Z, Mikó E, Kovács T, Jankó L, Csonka T, Lente G, Sebő É, Tóth J, Tóth D, Árkosy P, Boratkó A, Ujlaki G, Török M, Kovács I, Szabó J, Kiss B, Méhes G, Goedert JJ, Bai P. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress. Cancers (Basel) 2020;12:E2411. [PMID: 32854297 DOI: 10.3390/cancers12092411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
34 Andreeva NV, Gabbasova RR, Grivennikov SI. Microbiome in cancer progression and therapy. Curr Opin Microbiol 2020;56:118-26. [PMID: 33147555 DOI: 10.1016/j.mib.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Sharma VR, Singh M, Kumar V, Yadav M, Sehrawat N, Sharma DK, Sharma AK. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease. Semin Cancer Biol 2021;70:61-70. [PMID: 32693015 DOI: 10.1016/j.semcancer.2020.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Dilnaz F, Zafar F, Afroze T, Zakia UB, Chowdhury T, Swarna SS, Fathma S, Tasmin R, Sakibuzzaman M, Fariza TT, Eshan SH. Mediterranean Diet and Physical Activity: Two Imperative Components in Breast Cancer Prevention. Cureus 2021;13:e17306. [PMID: 34567862 DOI: 10.7759/cureus.17306] [Reference Citation Analysis]
37 Sipos A, Ujlaki G, Mikó E, Maka E, Szabó J, Uray K, Krasznai Z, Bai P. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med 2021;27:33. [PMID: 33794773 DOI: 10.1186/s10020-021-00295-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Kiss B, Mikó E, Sebő É, Toth J, Ujlaki G, Szabó J, Uray K, Bai P, Árkosy P. Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Cancers (Basel) 2020;12:E1068. [PMID: 32344895 DOI: 10.3390/cancers12051068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
39 Kovács P, Csonka T, Kovács T, Sári Z, Ujlaki G, Sipos A, Karányi Z, Szeőcs D, Hegedűs C, Uray K, Jankó L, Kiss M, Kiss B, Laoui D, Virág L, Méhes G, Bai P, Mikó E. Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer. Cancers (Basel) 2019;11:E1255. [PMID: 31461945 DOI: 10.3390/cancers11091255] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
40 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sári Z, Mikó E, Kovács T, Boratkó A, Ujlaki G, Jankó L, Kiss B, Uray K, Bai P. Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers (Basel) 2020;12:E2915. [PMID: 33050543 DOI: 10.3390/cancers12102915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, Mishra BN, Kaul S, Kharwar RN. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach. Semin Cancer Biol 2021:S1044-579X(21)00194-2. [PMID: 34216789 DOI: 10.1016/j.semcancer.2021.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Smolková K, Bai P. Editorial: Epithelial-Mesenchymal Transition: Yet Another Exciting Avenue in Cancer Metabolic Remodeling. Front Oncol 2020;10:628664. [PMID: 33585255 DOI: 10.3389/fonc.2020.628664] [Reference Citation Analysis]
44 Jarman R, Ribeiro-Milograna S, Kalle W. Potential of the Microbiome as a Biomarker for Early Diagnosis and Prognosis of Breast Cancer. J Breast Cancer 2020;23:579-87. [PMID: 33408884 DOI: 10.4048/jbc.2020.23.e60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sun T, Xue M, Yang J, Pei Z, Zhang N, Qin K, Liang H. Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases. J Sci Food Agric 2021;101:4456-63. [PMID: 33682122 DOI: 10.1002/jsfa.11202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Sędzikowska A, Szablewski L. Human Gut Microbiota in Health and Selected Cancers. Int J Mol Sci 2021;22:13440. [PMID: 34948234 DOI: 10.3390/ijms222413440] [Reference Citation Analysis]
47 Wang Z, Jiang Q, Dong C. Metabolic reprogramming in triple-negative breast cancer. Cancer Biol Med 2020;17:44-59. [PMID: 32296576 DOI: 10.20892/j.issn.2095-3941.2019.0210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
48 Chadha J, Nandi D, Atri Y, Nag A. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible. Semin Cancer Biol 2021;70:112-27. [PMID: 32717337 DOI: 10.1016/j.semcancer.2020.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
49 Parida S, Sharma D. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights. Cells 2020;9:E1091. [PMID: 32354130 DOI: 10.3390/cells9051091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
50 Sheweita SA, Alsamghan AS. Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer. Mediators Inflamm 2020;2020:4070419. [PMID: 32724295 DOI: 10.1155/2020/4070419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Nunes SC, Serpa J. Recycling the Interspecific Relations with Epithelial Cells: Bacteria and Cancer Metabolic Symbiosis. Adv Exp Med Biol 2020;1219:77-91. [PMID: 32130694 DOI: 10.1007/978-3-030-34025-4_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]